Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPHI: Prophylactic Levosimendan vs Milrinone in CABG Patients with Low Ejection Fraction
2004-002653-31Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis, heart failure with reduced ejection fraction (HFrEF) and perioperative cardiac dysfunction comparing Levosimendan (Simdax) arm with Milrinone (Corotrop) arm (2 arms). Primary endpoints: Cardiac index, Electrocardiogram (ECG) parameters and 9 more. Started Sep 2004; status: completed.
02
Drugs
levosimendanmilrinone
03
Conditions
coronary arteriosclerosisheart failure with reduced ejection fraction (HFrEF)perioperative cardiac dysfunction
Beyond the preview
Go deeper on 2004-002653-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002653-31.